Home » Analyst Articles – US

Myriad Genetics (MYGN) Lifted to “Buy” at Zacks Investment Research

Zacks Investment Research upgraded shares of Myriad Genetics (NASDAQ:MYGN) from a hold rating to a buy rating in a research report report published on Thursday. They currently have $32.00 price target on the stock. According to Zacks, “Over the past year, Myriad Genetics has outperformed its industry. The company observed strong growth in GeneSight, EndoPredict and Prolaris testing revenues. Further, management believes that Hereditary cancer pricing has remained stable on a sequential basis for four consecutive quarters. We are upbeat about... 
 

BTIG Research Cuts NuVasive (NUVA) Price Target to $59.00

NuVasive (NASDAQ:NUVA) had its price objective reduced by BTIG Research to $59.00 in a research note released on Thursday, The Fly reports. BTIG Research currently has a buy rating on the medical device company’s stock. The analysts noted that the move was a valuation call. A number of other research firms have also commented on NUVA. Royal Bank of Canada raised their price objective on NuVasive to $70.00 and gave the stock an outperform rating in a research note on Tuesday, November 27th. BidaskClub lowered NuVasive from a hold rating to... 
 

La Jolla Pharmaceutical (LJPC) Downgraded by Zacks Investment Research

Zacks Investment Research lowered shares of La Jolla Pharmaceutical (NASDAQ:LJPC) from a hold rating to a sell rating in a research note released on Thursday. According to Zacks, “LA JOLLA PHARMACEUTICAL CO. is engaged in the research and development of therapeutic products for the treatment of autoimmune and inflammatory diseases. “ Several other brokerages also recently issued reports on LJPC. ValuEngine downgraded La Jolla Pharmaceutical from a hold rating to a sell rating in a research note on Monday, October 8th. HC Wainwright... 
 

Huron Consulting Group (HURN) Downgraded by BidaskClub

BidaskClub downgraded shares of Huron Consulting Group (NASDAQ:HURN) from a buy rating to a hold rating in a report issued on Thursday. HURN has been the subject of several other reports. Zacks Investment Research raised Huron Consulting Group from a sell rating to a hold rating in a report on Thursday, October 4th. Barrington Research set a $57.00 price objective on Huron Consulting Group and gave the company a buy rating in a report on Wednesday, November 7th. Two research analysts have rated the stock with a hold rating and four have issued... 
 

Fidelity Southern (LION) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Fidelity Southern (NASDAQ:LION) from a hold rating to a buy rating in a research report report published on Thursday. They currently have $31.00 price objective on the financial services provider’s stock. According to Zacks, “Fidelity Southern Corporation, through its operating subsidiary Fidelity Bank, provides a wide range of banking, mortgage and investment services through branches in Atlanta, Georgia. Mortgage, construction, and automobile loans are also provided through offices in Jacksonville,... 
 

Ideal Power (IPWR) Lifted to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of Ideal Power (NASDAQ:IPWR) from a sell rating to a hold rating in a report issued on Thursday. According to Zacks, “Ideal Power, Inc. is engaged in development of a novel, patented power conversion technology called Power Packet Switching Architecture(TM). The company also provides photovoltaic inverters and battery converters for grid storage and electrified vehicle fast-charging infrastructure. In addition, it offers hybrid power conversion systems and power switches. Ideal Power, Inc. is based... 
 

Hawaiian (HA) Upgraded at ValuEngine

ValuEngine upgraded shares of Hawaiian (NASDAQ:HA) from a strong sell rating to a sell rating in a research report released on Thursday. A number of other brokerages have also weighed in on HA. BidaskClub upgraded shares of Hawaiian from a sell rating to a hold rating in a report on Saturday, September 29th. Imperial Capital reiterated an outperform rating and set a $59.00 target price (up from $57.00) on shares of Hawaiian in a research note on Tuesday, December 4th. Citigroup boosted their target price on shares of Hawaiian from $41.00 to $43.00... 
 

Falcon Minerals (FLMN) Raised to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Falcon Minerals (NASDAQ:FLMN) from a sell rating to a hold rating in a research note released on Thursday morning. According to Zacks, “Falcon Minerals Corporation own and acquire oil-weighted minerals. The company owns mineral, royalty and over-riding royalty interests primarily in the Eagle Ford and Austin Chalk in Karnes County, DeWitt County and Gonzales County Texas. Falcon Minerals Corporation, formerly named Osprey Energy Acquisition Corp., is based in San Diego, California. “ A... 
 

Gaming and Leisure Properties (GLPI) Raised to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of Gaming and Leisure Properties (NASDAQ:GLPI) from a hold rating to a buy rating in a research note published on Thursday. Zacks Investment Research currently has $39.00 price objective on the real estate investment trust’s stock. According to Zacks, “Gaming and Leisure Properties, Inc. is a self-administered, self-managed REIT primarily engaged in the property business, which will consist of owning, acquiring, developing, expanding, managing, and leasing gaming and related facilities. Gaming... 
 

Endo International (ENDP) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Endo International (NASDAQ:ENDP) (TSE:ENL) from a hold rating to a buy rating in a research note published on Thursday. The firm currently has $11.00 price target on the stock. According to Zacks, “Endo is in the process of redefining its business, given the persistent decline in the Generic business that is expected to face challenges. The focus now is on sterile injectables and Xiaflex. Demand for Xiaflex continues to be strong owing to high demand driven by increased demand in both Peyronie's... 
 

Fidus Investment (FDUS) Upgraded to “Hold” at ValuEngine

ValuEngine upgraded shares of Fidus Investment (NASDAQ:FDUS) from a sell rating to a hold rating in a research report sent to investors on Thursday morning. A number of other research firms also recently weighed in on FDUS. BidaskClub raised shares of Fidus Investment from a hold rating to a buy rating in a research report on Saturday, December 8th. TheStreet downgraded shares of Fidus Investment from a b- rating to a c+ rating in a research report on Thursday, December 20th. Finally, Zacks Investment Research downgraded shares of Fidus Investment... 
 

MKM Partners Boosts Lululemon Athletica (LULU) Price Target to $179.00

Lululemon Athletica (NASDAQ:LULU) had its price objective raised by MKM Partners from $177.00 to $179.00 in a research report report published on Wednesday morning, The Fly reports. The firm currently has a buy rating on the apparel retailer’s stock. Several other brokerages have also recently issued reports on LULU. B. Riley restated a neutral rating and issued a $155.00 target price (up previously from $141.00) on shares of Lululemon Athletica in a report on Tuesday, October 2nd. Royal Bank of Canada increased their price target on shares... 
 

BidaskClub Lowers Hailiang Education Group (HLG) to Strong Sell

BidaskClub cut shares of Hailiang Education Group (NASDAQ:HLG) from a sell rating to a strong sell rating in a research report released on Wednesday morning. NASDAQ:HLG traded down $0.70 on Wednesday, hitting $43.00. 11,835 shares of the stock were exchanged, compared to its average volume of 13,592. Hailiang Education Group has a 52 week low of $40.02 and a 52 week high of $88.92. Several institutional investors have recently bought and sold shares of HLG. Legal & General Group Plc acquired a new position in shares of Hailiang Education Group... 
 

Hospitality Properties Trust (HPT) Upgraded at ValuEngine

ValuEngine upgraded shares of Hospitality Properties Trust (NASDAQ:HPT) from a sell rating to a hold rating in a report released on Wednesday morning. HPT has been the subject of a number of other reports. Zacks Investment Research raised shares of Hospitality Properties Trust from a hold rating to a buy rating and set a $26.00 price target for the company in a report on Monday, December 24th. B. Riley reissued a buy rating and issued a $33.00 price target on shares of Hospitality Properties Trust in a report on Tuesday, November 6th. Finally,... 
 

HC Wainwright Reiterates $13.00 Price Target for Inovio Pharmaceuticals (INO)

HC Wainwright set a $13.00 price objective on Inovio Pharmaceuticals (NASDAQ:INO) in a research note released on Wednesday morning. The firm currently has a buy rating on the biopharmaceutical company’s stock. INO has been the subject of several other research reports. BidaskClub downgraded shares of Inovio Pharmaceuticals from a hold rating to a sell rating in a report on Friday, December 21st. Maxim Group reissued a buy rating and set a $8.00 price target on shares of Inovio Pharmaceuticals in a report on Tuesday, January 15th. Zacks Investment... 
 

Grupo Aeroportr dl Pcfco SAB de CV (PAC) Upgraded to “Buy” at Zacks Investment Research

Zacks Investment Research upgraded shares of Grupo Aeroportr dl Pcfco SAB de CV (NYSE:PAC) from a sell rating to a buy rating in a research note issued to investors on Thursday. The firm currently has $104.00 target price on the transportation company’s stock. According to Zacks, “Grupo Aeroportuario del Pacifico was constituted as part of the process of opening to the private investment the Mexican airport system. Currently the aeronautic infrastructure has become the base of every service of air transportation; constituting this a... 
 

Credit Suisse Group Reaffirms Hold Rating for PPG Industries (PPG)

Credit Suisse Group reiterated their hold rating on shares of PPG Industries (NYSE:PPG) in a research report sent to investors on Thursday morning. Credit Suisse Group currently has a $115.00 target price on the specialty chemicals company’s stock. Other equities research analysts have also issued research reports about the company. Northcoast Research set a $114.00 price objective on PPG Industries and gave the stock a buy rating in a report on Tuesday, October 9th. Deutsche Bank decreased their price objective on PPG Industries from $124.00... 
 

Newmont Mining’s (NEM) Buy Rating Reaffirmed at Credit Suisse Group

Credit Suisse Group restated their buy rating on shares of Newmont Mining (NYSE:NEM) in a research report released on Wednesday. Other analysts have also recently issued research reports about the company. ValuEngine raised Newmont Mining from a hold rating to a buy rating in a report on Friday, November 16th. BMO Capital Markets reaffirmed a buy rating and issued a $46.00 price target on shares of Newmont Mining in a report on Friday, September 21st. Canaccord Genuity raised Newmont Mining from a hold rating to a buy rating and raised their price... 
 

Magnolia Oil & Gas (MGY) Earns Buy Rating from Analysts at R. F. Lafferty

R. F. Lafferty assumed coverage on shares of Magnolia Oil & Gas (NYSE:MGY) in a report released on Thursday morning. The firm issued a buy rating and a $17.00 price objective on the stock. MGY has been the topic of a number of other reports. Citigroup assumed coverage on Magnolia Oil & Gas in a research report on Wednesday, January 9th. They issued a positive rating and a $16.00 target price on the stock. Oppenheimer began coverage on Magnolia Oil & Gas in a research report on Tuesday, January 8th. They set an outperform rating and a... 
 

Netflix (NFLX) PT Raised to $415.00 at Canaccord Genuity

Netflix (NASDAQ:NFLX) had its price objective hoisted by investment analysts at Canaccord Genuity from $400.00 to $415.00 in a research note issued on Friday. The firm presently has a “buy” rating on the Internet television network’s stock. Canaccord Genuity’s price objective indicates a potential upside of 22.38% from the company’s current price. NFLX has been the subject of a number of other reports. Bank of America restated a “buy” rating and issued a $450.00 target price (up from $440.00) on shares... 
 

MSA Safety (MSA) Stock Rating Lowered by Zacks Investment Research

MSA Safety (NYSE:MSA) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Friday. According to Zacks, “MSA Safety Inc. is engaged in the development, manufacture and supply of safety products that protect people and facility infrastructures. The company’s core product lines include self-contained breathing apparatus, fixed gas and flame detection systems, handheld gas detection instruments, industrial and fire service head protection products and fall... 
 

QUALCOMM (QCOM) Rating Reiterated by Barclays

QUALCOMM (NASDAQ:QCOM)‘s stock had its “buy” rating reissued by investment analysts at Barclays in a report issued on Friday. They presently have a $70.00 price target on the wireless technology company’s stock. Barclays‘s target price would indicate a potential upside of 26.65% from the stock’s current price. A number of other equities analysts also recently issued reports on QCOM. Zacks Investment Research downgraded QUALCOMM from a “strong-buy” rating to a “hold” rating in a research... 
 

Lakeland Bancorp (LBAI) Downgraded by Zacks Investment Research

Lakeland Bancorp (NASDAQ:LBAI) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Friday. According to Zacks, “LAKELAND BANCORP INC. is a bank holding company engaged in general banking business. “ Other research analysts have also recently issued research reports about the company. BidaskClub cut Lakeland Bancorp from a “sell” rating to a “strong sell” rating in a research note on Saturday, December 1st. FIG Partners raised shares... 
 

Maxim Integrated Products (MXIM) Stock Rating Upgraded by Zacks Investment Research

Zacks Investment Research upgraded shares of Maxim Integrated Products (NASDAQ:MXIM) from a sell rating to a hold rating in a report released on Wednesday morning. According to Zacks, “Maxim's high dependence on Samsung is a risk to its growth trajectory. Also, the company is suffering from sluggish bookings and weakening momentum across its customers. These are affecting the company’s position in the industrial market. Further, it is experiencing seasonal fluctuations in the consumer market which remains an overhang. Also, slowing... 
 

Parker-Hannifin (PH) Downgraded to Sell at Zacks Investment Research

Zacks Investment Research lowered shares of Parker-Hannifin (NYSE:PH) from a hold rating to a sell rating in a research report report published on Wednesday morning. According to Zacks, “Over the past year, Parker-Hannifin has underperformed the industry. Import duties on steel and aluminium, a stronger U.S. dollar and realignment expenses might continue to weigh over the company’s results in the quarters ahead. Also, we believe that a highly leveraged balance sheet can inflate the company's financial obligations and hurt profitability.... 
 

Sol Gel Technologies (SLGL) Cut to “Sell” at Zacks Investment Research

Zacks Investment Research cut shares of Sol Gel Technologies (NASDAQ:SLGL) from a hold rating to a sell rating in a research report released on Wednesday morning. According to Zacks, “Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical... 
 

Intercept Pharmaceuticals (ICPT) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Intercept Pharmaceuticals (NASDAQ:ICPT) from a sell rating to a hold rating in a report issued on Wednesday morning. According to Zacks, “Intercept got a significant boost with the approval of Ocaliva for the treatment of PBC.  Although sales had earlier taken a hit due to the safety issues regarding Ocaliva, management’s efforts to increase awareness about the updated level and promote Ocaliva, thereafter, is reaping results. Solid growth in new patient enrollment in the third-quarter... 
 

Revance Therapeutics (RVNC) Downgraded by Zacks Investment Research to Hold

Zacks Investment Research cut shares of Revance Therapeutics (NASDAQ:RVNC) from a buy rating to a hold rating in a report published on Wednesday. According to Zacks, “Revance is a Silicon Valley-based biotechnology company. The company is developing a portfolio of products for aesthetic medicine and underserved therapeutic specialties, including dermatology and neurology. Revance’s science is based upon a proprietary TransMTS┬« peptide technology, which when combined with active drug molecules, may help address current unmet needs.... 
 

Ceragon Networks (CRNT) Lifted to “Buy” at Zacks Investment Research

Zacks Investment Research upgraded shares of Ceragon Networks (NASDAQ:CRNT) from a hold rating to a buy rating in a report released on Wednesday morning. They currently have $4.50 price objective on the communications equipment provider’s stock. According to Zacks, “Ceragon Networks Ltd. is a leading provider of high-capacity wireless backhaul solutions for cellular and fixed wireless operators, enterprises and government organizations. Ceragon’s modular FibeAir product family is recognized as the gold standard for backhaul transmission... 
 

Covia (CVIA) Downgraded by Cowen

Cowen downgraded shares of Covia (NASDAQ:CVIA) from an outperform rating to a market perform rating in a research note issued to investors on Thursday morning, Marketbeat Ratings reports. Several other analysts have also issued reports on CVIA. Zacks Investment Research lowered shares of Covia from a hold rating to a sell rating in a research report on Tuesday, January 15th. Credit Suisse Group dropped their price objective on shares of Covia from $7.50 to $6.00 and set an underperform rating for the company in a research note on Thursday, November... 
 

TCG BDC (CGBD) Downgraded by Zacks Investment Research

Zacks Investment Research lowered shares of TCG BDC (NASDAQ:CGBD) from a hold rating to a sell rating in a research note published on Thursday. According to Zacks, “TCG BDC, Inc. is an externally managed specialty finance company. It focused on providing flexible financing solutions to middle market companies primarily located in the United States. TCG BDC, Inc. is based in New York, United States. “ A number of other research firms also recently issued reports on CGBD. Wells Fargo & Co cut their price target on TCG BDC from $17.75... 
 

Radian Group (RDN) Raised to Strong-Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of Radian Group (NYSE:RDN) from a hold rating to a strong-buy rating in a research report report published on Thursday morning. They currently have $20.00 price objective on the insurance provider’s stock. According to Zacks, “Shares of Radian have outperformed the industry in a year’s time. Radian is poised for growth on expansive mortgage and real estate service offerings, declining delinquency, lower levels of paid claims and an improving risk-based capital ratio. It is restructuring... 
 

Smart & Final Stores (SFS) Cut to Hold at Zacks Investment Research

Zacks Investment Research downgraded shares of Smart & Final Stores (NYSE:SFS) from a buy rating to a hold rating in a research note released on Thursday morning. According to Zacks, “Smart & Final Stores, Inc. is a value-oriented food and everyday staples retailer that serves household and business customers. It operates grocery and foodservice stores under the Smart & Final, Smart & Final Extra! and Cash & Carry Smart Foodservice banners in California, Oregon, Washington, Arizona, Nevada, Idaho. The Company’s... 
 

ValuEngine Lowers Rudolph Technologies (RTEC) to Sell

ValuEngine lowered shares of Rudolph Technologies (NYSE:RTEC) from a hold rating to a sell rating in a research report report published on Thursday morning. Other research analysts have also issued research reports about the stock. Stifel Nicolaus reduced their price objective on shares of Rudolph Technologies from $35.00 to $30.00 and set a buy rating on the stock in a research note on Thursday, October 4th. B. Riley reduced their price objective on shares of Rudolph Technologies from $36.00 to $30.00 and set a buy rating on the stock in a research... 
 

New Senior Investment Group (SNR) Raised to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of New Senior Investment Group (NYSE:SNR) from a sell rating to a hold rating in a report issued on Wednesday. According to Zacks, “New Senior Investment Group Inc. is a real estate investment trust focused on investing in senior housing properties across the United States. It operates in two reportable segments: Managed Properties and Triple Net Lease Properties. The Company’s managed portfolio includes assisted living, memory care and independent living properties. Its triple net lease portfolio... 
 

Luxfer (LXFR) Lifted to “Buy” at Zacks Investment Research

Zacks Investment Research upgraded shares of Luxfer (NYSE:LXFR) from a hold rating to a buy rating in a research note released on Thursday. Zacks Investment Research currently has $21.00 price target on the industrial products company’s stock. According to Zacks, “Luxfer Holdings PLC is a materials technology company specialising in the design, manufacture and supply of high-performance materials, components and gas cylinders. The company had two divisions, Elektron and Gas Cylinders. The Elektron division focuses on speciality materials... 
 

Laboratory Corp. of America (LH) Lifted to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Laboratory Corp. of America (NYSE:LH) from a sell rating to a hold rating in a research note released on Thursday morning. According to Zacks, “Acquisitions and organic volume expansion positively contributed to LabCorp Diagnostics business in the last-reported quarter. This apart, Covance Drug Development has reported sturdy growth. This uptrend was primarily owing to strategic acquisitions and robust organic growth. On the negative side, following a dismal third quarter show, shares of LabCorp... 
 

Credit Suisse Group Analysts Give Juniper Networks (JNPR) a $21.00 Price Target

Credit Suisse Group set a $21.00 price objective on Juniper Networks (NYSE:JNPR) in a research note issued to investors on Wednesday morning. The brokerage currently has a sell rating on the network equipment provider’s stock. Several other brokerages have also recently commented on JNPR. Zacks Investment Research upgraded Juniper Networks from a hold rating to a buy rating and set a $33.00 price target for the company in a research report on Wednesday, September 26th. Rosenblatt Securities reiterated a sell rating and set a $24.00 price... 
 

Kimberly Clark (KMB) Raised to Overweight at JPMorgan Chase & Co.

Kimberly Clark (NYSE:KMB) was upgraded by equities research analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research report issued on Friday, Marketbeat.com reports. The brokerage presently has a $129.00 price target on the stock. JPMorgan Chase & Co.‘s target price would suggest a potential upside of 10.38% from the company’s previous close. A number of other analysts have also recently commented on KMB. Atlantic Securities began coverage on shares of Kimberly Clark... 
 

International Paper (IP) PT Lowered to $46.00 at Deutsche Bank

International Paper (NYSE:IP) had its price objective decreased by Deutsche Bank from $55.00 to $46.00 in a report published on Thursday morning, The Fly reports. Deutsche Bank currently has a hold rating on the basic materials company’s stock. A number of other research firms have also recently commented on IP. Citigroup dropped their price objective on International Paper from $67.00 to $51.00 and set a buy rating for the company in a research report on Thursday, October 11th. Barclays dropped their price objective on International Paper... 
 

Generac (GNRC) Lifted to “Buy” at Zacks Investment Research

Zacks Investment Research upgraded shares of Generac (NYSE:GNRC) from a hold rating to a buy rating in a research note released on Thursday morning. Zacks Investment Research currently has $60.00 price objective on the technology company’s stock. According to Zacks, “Generac Holdings Inc. is a manufacturer of backup power generation products serving residential, light commercial and industrial markets. The Company designs, engineers, manufactures, and markets a range of automatic, stationary standby, and portable generators. Generac’s... 
 

Halliburton (HAL) Lifted to Outperform at Cowen

Cowen upgraded shares of Halliburton (NYSE:HAL) from a market perform rating to an outperform rating in a report issued on Thursday morning, MarketBeat.com reports. The brokerage currently has $35.00 target price on the oilfield services company’s stock, down from their previous target price of $45.00. A number of other equities analysts have also commented on HAL. Zacks Investment Research raised shares of Halliburton from a strong sell rating to a hold rating in a report on Monday, September 24th. Wells Fargo & Co reduced their target... 
 

HubSpot (HUBS) Downgraded by Zacks Investment Research

Zacks Investment Research cut shares of HubSpot (NYSE:HUBS) from a buy rating to a hold rating in a research report sent to investors on Thursday morning. According to Zacks, “HubSpot provides inbound marketing and sales application over the cloud. The company also raised its fiscal 2018 guidance. We believe portfolio expansion and collaborations bode well. The company is benefitting from an expanding international footprint. Robust performance of Hubspot One and Hubspot CRM tools is a positive. HubSpot’s product portfolio is gaining... 
 

Rubius Therapeutics (RUBY) Rating Increased to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of Rubius Therapeutics (NASDAQ:RUBY) from a hold rating to a buy rating in a research report released on Wednesday morning. The firm currently has $16.00 price objective on the stock. According to Zacks, “Rubius Therapeutics, Inc. is a bio-technology company. It develops cellular therapies for the treatment of auto-immune, metabolic and other diseases. Rubius Therapeutics, Inc. is based in Cambridge, United States. “ Other analysts have also issued research reports about the company. ValuEngine... 
 

Capital One Financial Lowers Superior Energy Services (SPN) to Equal Weight

Capital One Financial lowered shares of Superior Energy Services (NYSE:SPN) from an overweight rating to an equal weight rating in a research report report published on Wednesday, MarketBeat reports. Other equities research analysts also recently issued reports about the stock. Credit Suisse Group downgraded shares of Superior Energy Services from an outperform rating to a neutral rating and reduced their price objective for the stock from $10.00 to $4.50 in a research report on Wednesday, December 19th. Barclays set a $10.00 price objective on... 
 

Zacks Investment Research Lowers IMPINJ (PI) to Hold

Zacks Investment Research cut shares of IMPINJ (NASDAQ:PI) from a buy rating to a hold rating in a research note issued to investors on Wednesday. According to Zacks, “Impinj, Inc. is a provider of referral and information network radio frequency identification solutions to the retail, pharmaceutical, healthcare, food and beverage and other industries. The company’s products include Indy Reader Chips which consists of integrated radio chips and supporting SDKs; Monza Tag Chips, which deliver memory options and extended features to RFID... 
 

Cathay General Bancorp (CATY) Cut to Sell at Zacks Investment Research

Zacks Investment Research cut shares of Cathay General Bancorp (NASDAQ:CATY) from a hold rating to a sell rating in a report released on Thursday morning. According to Zacks, “Cathay General Bancorp is the one-bank holding company for Cathay Bank, a California state-chartered bank. Cathay Bank offers a wide range of financial services. Cathay Bank currently operates branches in California, New York State, Massachusetts, Houston, Texas, Washington State, and representative offices in Hong Kong and Shanghai, China. In addition, Cathay Bank’s... 
 

Blackrock Capital Investment (BKCC) Downgraded by Zacks Investment Research

Zacks Investment Research lowered shares of Blackrock Capital Investment (NASDAQ:BKCC) from a hold rating to a sell rating in a research note released on Thursday morning. According to Zacks, “BlackRock Kelso Capital Corporation provides responsive, creative and flexible capital solutions to middle-market companies. BlackRock Kelso Capital provides middle-market companies with flexible financing solutions, including senior and junior secured, unsecured and subordinated debt securities and loans, and equity securities. The Companies strategy... 
 

Activision Blizzard (ATVI) Lowered to “Strong Sell” at Zacks Investment Research

Zacks Investment Research downgraded shares of Activision Blizzard (NASDAQ:ATVI) from a hold rating to a strong sell rating in a report released on Wednesday morning. According to Zacks, “Activision’s split with Destiny franchise is expected to negatively impact its top-line in the near-term. Intense competition from the likes of EA and Take-Two Interactive is expected to hurt market share expansion. Declining bookings and MAUs are a headwind. Lower revenues from King Digital is also an overhang. Continued investment in the digital... 
 

Zacks Investment Research Downgrades Aquestive Therapeutics (AQST) to Sell

Zacks Investment Research cut shares of Aquestive Therapeutics (NASDAQ:AQST) from a hold rating to a sell rating in a report published on Wednesday. According to Zacks, “Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. It commercializes medicines to solve critical health care problems as well as engages on late-stage proprietary product pipeline which focuses on the treatment of diseases of central nervous system. Aquestive Therapeutics, Inc. is based in NJ, United States. “ Other analysts have also issued research... 
 
© 2006-2019 Ticker Report